These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 38284882)

  • 1. HDAC Inhibition Induces CD26 Expression on Multiple Myeloma Cells via the c-Myc/Sp1-mediated Promoter Activation.
    Nishida H; Suzuki R; Nakajima K; Hayashi M; Morimoto C; Yamada T
    Cancer Res Commun; 2024 Feb; 4(2):349-364. PubMed ID: 38284882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase inhibitors modulate the transcriptional regulation of guanylyl cyclase/natriuretic peptide receptor-a gene: interactive roles of modified histones, histone acetyltransferase, p300, AND Sp1.
    Kumar P; Tripathi S; Pandey KN
    J Biol Chem; 2014 Mar; 289(10):6991-7002. PubMed ID: 24451378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PSG gene expression is up-regulated by lysine acetylation involving histone and nonhistone proteins.
    Camolotto SA; Racca AC; Ridano ME; Genti-Raimondi S; Panzetta-Dutari GM
    PLoS One; 2013; 8(2):e55992. PubMed ID: 23418492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trichostatin A induces 5-lipoxygenase promoter activity and mRNA expression via inhibition of histone deacetylase 2 and 3.
    Pufahl L; Katryniok C; Schnur N; Sorg BL; Metzner J; Grez M; Steinhilber D
    J Cell Mol Med; 2012 Jul; 16(7):1461-73. PubMed ID: 21883892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase inhibitors SAHA and sodium butyrate block G1-to-S cell cycle progression in neurosphere formation by adult subventricular cells.
    Zhou Q; Dalgard CL; Wynder C; Doughty ML
    BMC Neurosci; 2011 May; 12():50. PubMed ID: 21615950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of class I isoform histone deacetylase depletion and enzymatic inhibition by belinostat or valproic acid in HeLa cells.
    Dejligbjerg M; Grauslund M; Litman T; Collins L; Qian X; Jeffers M; Lichenstein H; Jensen PB; Sehested M
    Mol Cancer; 2008 Sep; 7():70. PubMed ID: 18789133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using Histone Deacetylase Inhibitors to Analyze the Relevance of HDACs for Translation.
    Hutt DM; Roth DM; Marchal C; Bouchecareilh M
    Methods Mol Biol; 2017; 1510():77-91. PubMed ID: 27761814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoregulation of mouse histone deacetylase 1 expression.
    Schuettengruber B; Simboeck E; Khier H; Seiser C
    Mol Cell Biol; 2003 Oct; 23(19):6993-7004. PubMed ID: 12972616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone Deacetylase Inhibitors (HDACi) Cause the Selective Depletion of Bromodomain Containing Proteins (BCPs).
    Mackmull MT; Iskar M; Parca L; Singer S; Bork P; Ori A; Beck M
    Mol Cell Proteomics; 2015 May; 14(5):1350-60. PubMed ID: 25755299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD26 is a potential therapeutic target by humanized monoclonal antibody for the treatment of multiple myeloma.
    Nishida H; Hayashi M; Morimoto C; Sakamoto M; Yamada T
    Blood Cancer J; 2018 Oct; 8(11):99. PubMed ID: 30348967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational combination treatment with histone deacetylase inhibitors and immunomodulatory drugs in multiple myeloma.
    Hideshima T; Cottini F; Ohguchi H; Jakubikova J; Gorgun G; Mimura N; Tai YT; Munshi NC; Richardson PG; Anderson KC
    Blood Cancer J; 2015 May; 5(5):e312. PubMed ID: 25978432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of histone deacetylation in cell-specific expression of endothelial nitric-oxide synthase.
    Gan Y; Shen YH; Wang J; Wang X; Utama B; Wang J; Wang XL
    J Biol Chem; 2005 Apr; 280(16):16467-75. PubMed ID: 15722551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1.
    Gui CY; Ngo L; Xu WS; Richon VM; Marks PA
    Proc Natl Acad Sci U S A; 2004 Feb; 101(5):1241-6. PubMed ID: 14734806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-Myc Modulation and Acetylation Is a Key HDAC Inhibitor Target in Cancer.
    Nebbioso A; Carafa V; Conte M; Tambaro FP; Abbondanza C; Martens J; Nees M; Benedetti R; Pallavicini I; Minucci S; Garcia-Manero G; Iovino F; Lania G; Ingenito C; Belsito Petrizzi V; Stunnenberg HG; Altucci L
    Clin Cancer Res; 2017 May; 23(10):2542-2555. PubMed ID: 27358484
    [No Abstract]   [Full Text] [Related]  

  • 15. SIRT1 activation enhances HDAC inhibition-mediated upregulation of GADD45G by repressing the binding of NF-κB/STAT3 complex to its promoter in malignant lymphoid cells.
    Scuto A; Kirschbaum M; Buettner R; Kujawski M; Cermak JM; Atadja P; Jove R
    Cell Death Dis; 2013 May; 4(5):e635. PubMed ID: 23681230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The histone deacetylase inhibitor trichostatin a decreases lymphangiogenesis by inducing apoptosis and cell cycle arrest via p21-dependent pathways.
    Hrgovic I; Doll M; Kleemann J; Wang XF; Zoeller N; Pinter A; Kippenberger S; Kaufmann R; Meissner M
    BMC Cancer; 2016 Sep; 16(1):763. PubMed ID: 27716272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel orally active proteasome inhibitor K-7174 exerts anti-myeloma activity in vitro and in vivo by down-regulating the expression of class I histone deacetylases.
    Kikuchi J; Yamada S; Koyama D; Wada T; Nobuyoshi M; Izumi T; Akutsu M; Kano Y; Furukawa Y
    J Biol Chem; 2013 Aug; 288(35):25593-25602. PubMed ID: 23878197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay between PKCδ and Sp1 on histone deacetylase inhibitor-mediated Epstein-Barr virus reactivation.
    Tsai PF; Lin SJ; Weng PL; Tsai SC; Lin JH; Chou YC; Tsai CH
    J Virol; 2011 Mar; 85(5):2373-85. PubMed ID: 21159880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MYC directs transcription of MCL1 and eIF4E genes to control sensitivity of gastric cancer cells toward HDAC inhibitors.
    Labisso WL; Wirth M; Stojanovic N; Stauber RH; Schnieke A; Schmid RM; Krämer OH; Saur D; Schneider G
    Cell Cycle; 2012 Apr; 11(8):1593-602. PubMed ID: 22456335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of histone deacetylases by Trichostatin A leads to a HoxB4-independent increase of hematopoietic progenitor/stem cell frequencies as a result of selective survival.
    Obier N; Uhlemann CF; Müller AM
    Cytotherapy; 2010 Nov; 12(7):899-908. PubMed ID: 20210674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.